Yep, I am stating the obvious and exactly why the stock on at $0.038 from $1 only four years ago, but $580K in receipts for an operational cash outflow of $630K. That's still crap.
31% YoY sales growth and the 1/3 workforce costs cutting still only got it to a $630K operational outflow.
Unless this thing suddenly doubles sales, it needs a cash injection from alluded to CellHeal or Innoventure deals soon.
Absolute binary option investment. Deal(s) or to the wall in a year. By far the riskiest investment in my portfolio. SP, IMO, will fly on a deal(s) or fizzle to zero on no deals. Such compelling technology, so poorly managed.
OSX Price at posting:
3.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)